A case of multiple sclerosis with negatively converted anti ‐natalizumab antibodies
ConclusionsEven if the neutralizing antibodies against natalizumab are positive, treatment continuation may be considered if the therapeutic effect is certain and the side effects are within the allowable range.
Source: Clinical and Experimental Neuroimmunology - Category: Neurology Authors: Katsuichi Miyamoto,
Susumu Kusunoki Tags: CASE REPORT Source Type: research